Liposomal Membranes Osmotic Stress Spray-Drying Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current liposome formulations face challenges in maintaining the stability and controlled release of lipophilic active agents, particularly during manufacturing and storage, due to physical and chemical degradation processes, which limits their shelf life and in-use stability.
Innovation Solution
The process involves creating stressed liposomes by applying osmotic forces through an osmotic gradient, where the osmolarity inside the liposomal encapsulated volume is higher than outside, to enhance the loading capacity and stability of lipophilic compounds within the liposomal membranes, and using spray-drying for dehydration to maintain stability during processing and storage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If liposomes are stored as liquid formulations, then they are ready for immediate administration, but they undergo chemical and physical degradation processes limiting shelf life stability
Solution Approach 1:
The invention utilizes phase transition by dehydrating liquid liposome formulations into dry powders for long-term storage, then rehydrating them before administration. This transitions the formulation from liquid phase (unstable for long storage) to solid phase (stable for long-term storage), resolving the contradiction between immediate readiness and shelf life stability.
Solution Approach 2:
The invention applies preliminary action by performing dehydration and stabilization treatments before storage to prevent degradation during long-term keeping. The liposomes are pre-treated with stabilizing agents and dehydrated to remove water that would otherwise promote chemical and physical degradation during storage.
2Stability of the object's composition
If liposomes are dehydrated by freeze-drying, then long term stability is enhanced, but the process is time-consuming and costly
Solution Approach 1:
The invention replaces the expensive, time-consuming freeze-drying process with a more economical and efficient spray-drying method. Spray-drying uses hot gas flow to rapidly evaporate water from atomized liposome solution, achieving dehydration and stabilization much faster and at lower cost while maintaining long-term stability.
Solution Approach 2:
The invention substitutes the mechanical freeze-drying system (requiring freezing chambers and vacuum equipment) with a thermal spray-drying system that uses atomization and hot gas flow. This replacement maintains the dehydration and stabilization functions while dramatically improving manufacturing efficiency and reducing costs.
3Productivity
If liposomes are dehydrated by spray-drying, then productivity increases and costs reduce, but organic solvent residues remain in the formulation
Solution Approach 1:
The invention applies extraction by removing organic solvent residues from the spray-dried liposome formulation through washing with water or aqueous buffers. The dried powder is resuspended and washed to extract and eliminate trace organic solvents, then re-dried to produce a clean, safe formulation free of harmful residues.
Solution Approach 2:
The invention discards the harmful organic solvent residues by washing them away during the rehydration process, while recovering and retaining the valuable liposome formulation. The washing step selectively removes contaminants while preserving the intended active components.
4Reliability
If lipophilic compounds are loaded into liposomal membranes, then therapeutic efficacy is improved, but physical and chemical degradation increases during storage
Solution Approach 1:
The invention applies beforehand cushioning by incorporating stabilizing agents (such as sugars, polymers, or antioxidants) into the liposomal formulation before storage. These agents cushion and protect the lipophilic compounds embedded in the membrane from physical and chemical degradation during storage, maintaining both therapeutic efficacy and stability.
Solution Approach 2:
The invention creates composite materials by combining lipophilic therapeutic compounds with stabilizing agents and liposomal membranes in a formulated system. This composite structure provides both the therapeutic function of the lipophilic compound and the protective stabilization from the formulated matrix, resolving the contradiction between efficacy and storage stability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly improves the stability and loading efficacy of lipophilic compounds, reducing their release and maintaining a homogeneous size distribution, thereby extending the shelf life and in-use stability of liposomal formulations, facilitating large-scale production with reduced costs and minimal organic solvent residues.
Implementation Method 1
the osmolarity of the aqueous phase inside the liposomally encapsulated volume, Oin, is higher than the aqueous phase outside the liposomally encapsulated volume, Oout
Implementation Method 2
using spray-drying for dehydration to maintain stability during processing and storage
Data Source
AI summary
The present invention relates to the preparation of liposomes with enhanced loading capacity for pharmaceutically and/or diagnostically active agents and/or cosmetic agents which are substantially solubilized by the liposomal membranes, to liposome dispersions with enhanced stability with respect to release of the active agent and/or cosmetic agent from the liposomes obtainable by the process, and to pharmaceutical or cosmetic compositions comprising said stabilized liposome dispersions. The preparation may involve dehydration and rehydration steps of liposome dispersions which may be carried out by spray drying.